BRPI0308445A2 - complexos de rápida dissolução, diretamente compressíveis, sem sabor e formulações farmacêuticas dos mesmos - Google Patents
complexos de rápida dissolução, diretamente compressíveis, sem sabor e formulações farmacêuticas dos mesmosInfo
- Publication number
- BRPI0308445A2 BRPI0308445A2 BRPI0308445A BR0308445A BRPI0308445A2 BR PI0308445 A2 BRPI0308445 A2 BR PI0308445A2 BR PI0308445 A BRPI0308445 A BR PI0308445A BR 0308445 A BR0308445 A BR 0308445A BR PI0308445 A2 BRPI0308445 A2 BR PI0308445A2
- Authority
- BR
- Brazil
- Prior art keywords
- flavorless
- pharmaceutical formulations
- fast dissolving
- directly compressible
- complexes
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN207DE2002 | 2002-03-08 | ||
PCT/IN2003/000048 WO2003075829A2 (en) | 2002-03-08 | 2003-03-07 | Tasteless directly compressible fast-dissolving complexes and pharmaceutical formulations thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0308445A2 true BRPI0308445A2 (pt) | 2016-08-02 |
Family
ID=27773181
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0308445A BRPI0308445A2 (pt) | 2002-03-08 | 2003-03-07 | complexos de rápida dissolução, diretamente compressíveis, sem sabor e formulações farmacêuticas dos mesmos |
Country Status (7)
Country | Link |
---|---|
US (1) | US20030170310A1 (pt) |
AU (1) | AU2003209673B2 (pt) |
BR (1) | BRPI0308445A2 (pt) |
MA (1) | MA27193A1 (pt) |
MX (1) | MXPA04008737A (pt) |
TN (1) | TNSN04173A1 (pt) |
WO (1) | WO2003075829A2 (pt) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9703673D0 (en) * | 1997-02-21 | 1997-04-09 | Bradford Particle Design Ltd | Method and apparatus for the formation of particles |
GB0027357D0 (en) * | 2000-11-09 | 2000-12-27 | Bradford Particle Design Plc | Particle formation methods and their products |
GB0208742D0 (en) | 2002-04-17 | 2002-05-29 | Bradford Particle Design Ltd | Particulate materials |
GB0216562D0 (en) | 2002-04-25 | 2002-08-28 | Bradford Particle Design Ltd | Particulate materials |
US9339459B2 (en) | 2003-04-24 | 2016-05-17 | Nektar Therapeutics | Particulate materials |
JP2006525303A (ja) | 2003-05-08 | 2006-11-09 | ネクター セラピューティクス ユーケー リミティド | 微粒子物質 |
US7282217B1 (en) * | 2003-08-29 | 2007-10-16 | Kv Pharmaceutical Company | Rapidly disintegrable tablets |
DE10351448A1 (de) * | 2003-11-04 | 2005-06-09 | Bayer Healthcare Ag | Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften |
TR200606412T2 (tr) * | 2004-03-19 | 2007-01-22 | Eczaciba�I �Zg�N K�Myasal �R�Nler San. Ve T�C. A �. | Lipit kaplı sefuroksim aksetil hazırlanması |
US20070092553A1 (en) * | 2005-10-21 | 2007-04-26 | Pfab Lp | Compositions and methods of making rapidly dissolving lonically masked formulations |
EP2043613A1 (en) * | 2006-07-14 | 2009-04-08 | Fmc Corporation | Solid form |
HUE026884T2 (en) * | 2007-02-11 | 2016-08-29 | Map Pharmaceuticals Inc | DHE is a therapeutic method of administration for the rapid relief of migraine while minimizing side effects |
WO2008114280A1 (en) * | 2007-03-21 | 2008-09-25 | Lupin Limited | Novel reduced dose pharmaceutical compositions of fexofenadine and pseudoephedrine |
US20080311162A1 (en) * | 2007-05-16 | 2008-12-18 | Olivia Darmuzey | Solid form |
CA2782285A1 (en) | 2009-12-02 | 2011-06-09 | Luigi Mapelli | Fexofenadine microcapsules and compositions containing them |
EP2640736B1 (en) | 2010-11-19 | 2016-08-31 | Cargill, Incorporated | Method for the enrichment of rebaudioside b and/or rebaudioside d in stevia-derived glycoside compositions using adsorb-desorb chromatography with a macroporous neutral adsorbent resin |
CA2767773C (en) | 2011-02-11 | 2015-11-24 | Grain Processing Corporation | Composition comprising a salt and a crystallization interrupter |
JP2016523928A (ja) * | 2013-07-03 | 2016-08-12 | アール.ピー.シェーラー テクノロジーズ、エルエルシー | フェキソフェナジンを有するカプセル製剤 |
US11727516B2 (en) | 2019-06-26 | 2023-08-15 | PharmaCCX, Inc. | System and methods for securing a drug therapy |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5840529B2 (ja) * | 1975-09-29 | 1983-09-06 | 明治製菓株式会社 | ケイコウヨウセイザイノセイホウ |
KR960011236B1 (ko) * | 1987-05-08 | 1996-08-21 | 스미스 클라인 앤드 프렌취 라보라토리스 리미티드 | 제약학적 조성물 및 고체 제형 |
NL193682C (nl) * | 1987-05-14 | 2000-07-04 | Glaxo Group Ltd | Beklede cefuroximaxetilsamenstelling. |
US4808411A (en) * | 1987-06-05 | 1989-02-28 | Abbott Laboratories | Antibiotic-polymer compositions |
US4916161A (en) * | 1988-10-25 | 1990-04-10 | Bristol-Myers Squibb | Taste-masking pharmaceutical agents |
US5635200A (en) * | 1992-10-16 | 1997-06-03 | Glaxo Group Limited | Taste-making compositions of ranitidine |
US6027746A (en) * | 1997-04-23 | 2000-02-22 | Warner-Lambert Company | Chewable soft gelatin-encapsulated pharmaceutical adsorbates |
FR2776302B1 (fr) * | 1998-03-19 | 2002-04-12 | Hoechst Marion Roussel Inc | Nouveau procede de preparation de la fexofenadine |
US6051585A (en) * | 1998-12-07 | 2000-04-18 | Weinstein; Robert E. | Single-dose antihistamine/decongestant formulations for treating rhinitis |
US6723348B2 (en) * | 2001-11-16 | 2004-04-20 | Ethypharm | Orodispersible tablets containing fexofenadine |
US6667026B1 (en) * | 2002-03-15 | 2003-12-23 | Pocono Falls, Inc. | Allergic contact dermatitis treatment and composition therefor |
-
2003
- 2003-03-07 BR BRPI0308445A patent/BRPI0308445A2/pt not_active IP Right Cessation
- 2003-03-07 US US10/383,433 patent/US20030170310A1/en not_active Abandoned
- 2003-03-07 MX MXPA04008737A patent/MXPA04008737A/es active IP Right Grant
- 2003-03-07 WO PCT/IN2003/000048 patent/WO2003075829A2/en not_active Application Discontinuation
- 2003-03-07 AU AU2003209673A patent/AU2003209673B2/en not_active Ceased
-
2004
- 2004-09-08 TN TNP2004000173A patent/TNSN04173A1/en unknown
- 2004-10-08 MA MA27896A patent/MA27193A1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
WO2003075829A2 (en) | 2003-09-18 |
MXPA04008737A (es) | 2005-07-13 |
US20030170310A1 (en) | 2003-09-11 |
AU2003209673B2 (en) | 2007-10-18 |
TNSN04173A1 (en) | 2007-03-12 |
MA27193A1 (fr) | 2005-01-03 |
WO2003075829A3 (en) | 2004-11-18 |
AU2003209673A1 (en) | 2003-09-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0308445A2 (pt) | complexos de rápida dissolução, diretamente compressíveis, sem sabor e formulações farmacêuticas dos mesmos | |
ITTO20010005A0 (it) | Formulazione farmaceutica. | |
NO20033384L (no) | Farmasoytisk formulering | |
NO20003196L (no) | Umiddelbart opplösende doseringsformulering | |
IS7946A (is) | Lyf | |
PT1501534E (pt) | Formulacoes farmaceuticas | |
NO20033785D0 (no) | Farmasöytisk formulering | |
FI7846U1 (fi) | Farmaseuttinen valmiste, joka sisältää oksikodonia ja naloksonia | |
FI20011478A (fi) | Farmaseuttinen koostumus | |
PT1467724E (pt) | Composicao farmaceutica orodispersavel de agomelatina | |
NO20035627D0 (no) | Farmasöytisk formulering | |
FR2802423B1 (fr) | Compositions pharmaceutiques | |
DE60217390D1 (de) | Bicalutamid enthaltende pharmazeutische zusammensetzung | |
NO20043576L (no) | Pharmaceutical formulation comprising melatonin | |
DK1474152T3 (da) | Orodispergerbar farmaceutisk sammensætning omfattende ivabradin | |
AR025867A1 (es) | Formulacion portasdora farmaceutica | |
NO20016430D0 (no) | Farmasöytisk kompleks | |
DE10291905D2 (de) | Pharmazeutische Zusammensetzung | |
NO20004816D0 (no) | Ny farmasøytisk formulering | |
EE200300465A (et) | Püridoindolooni derivaatidel põhinevad farmatseutilised kompositsioonid | |
DE10107261B4 (de) | Pharmazeutische Zusammensetzung | |
NO20044164L (no) | Farmasoytiske sammensetninger | |
DE112004001429D2 (de) | Pharmazeutischer Wirkstoff | |
NO20041236L (no) | Farmasoytisk formulering | |
SE0201660D0 (sv) | Pharmaceutical formulation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06H | Technical and formal requirements: requirement cancelled [chapter 6.8 patent gazette] |
Free format text: FOI ANULADO O DESPACHO 6.7 DA RPI 1873 DE 28/11/2006 POR TER SIDO INDEVIDO. |
|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B08F | Application fees: application dismissed [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 11A, 12A E 13A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |